| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |